Given neuronal loss and astrogliosis are prominent hallmarks of AD pathogenesis, we were unable to fully discern whether the transcript-level variation associated with tau pathology reflects changes in cell composition associated with pathology. This evidence concerns the gene MAPT and Alzheimer disease.